BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38318896)

  • 1. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
    Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Medication-Related Osteonecrosis of the Jaws without Segmental Resections: A Case Series.
    Fernandes TL; Viezzer Fernandes B; Franco GCN
    Am J Case Rep; 2024 Feb; 25():e942980. PubMed ID: 38404023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
    Ikesue H; Mouri M; Tomita H; Hirabatake M; Ikemura M; Muroi N; Yamamoto S; Takenobu T; Tomii K; Kawakita M; Katoh H; Ishikawa T; Yasui H; Hashida T
    Support Care Cancer; 2021 Aug; 29(8):4763-4772. PubMed ID: 33527228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the lower jaw without osteolysis on computed tomography images.
    Kojima Y; Sawada S; Sakamoto Y
    J Bone Miner Metab; 2024 Jan; 42(1):27-36. PubMed ID: 38194089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study.
    Ristow O; Rückschloß T; Bodem J; Berger M; Bodem E; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2018 May; 46(5):815-824. PubMed ID: 29631942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
    Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
    Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
    Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
    Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
    Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
    BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report.
    Wu XH; Chen SW
    Medicine (Baltimore); 2023 Jul; 102(29):e34260. PubMed ID: 37478232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of pathological characteristics of medication-related osteonecrosis of the jaw and discussion of clinical treatment strategies based on the pathological analysis results].
    Guo YX; Zhang JY; Wang DC; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1190-1195. PubMed ID: 36533354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Challenges in Soft Tissue Reconstruction in Patients With MRONJ - The Nasolabial Flap.
    Dudde F; Barbarewicz F; Henkel KO
    Anticancer Res; 2023 Aug; 43(8):3709-3713. PubMed ID: 37500150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the preliminary clinical effect of flap-raising combined with cortical-perforation technique in tooth extraction cases of patients with potential risk of medication-related osteonecrosis of the jaw].
    Guo YX; Wang DC; Liu XJ; Wang EB; An JG; Peng X; Guo CB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 May; 56(5):452-457. PubMed ID: 33904280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.